Neogen Chemicals Regulatory Approval
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
68 announcements with these filters
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
A HUF of a director of Neogen's wholly owned subsidiary sold 2,361 shares on 5-6 November 2026. Sale consideration totals about ₹0.59 crore.
Neogen Chemicals seeks shareholder approval via postal ballot for related party transactions with a step-down subsidiary. E-voting runs until December 6, 2026.
Revenue rose 42% to ₹296 Cr and consolidated PAT rose 144% to ₹8 Cr, but a large standalone-to-consolidated gap shows the Neogen Ionics drag. Net debt is ₹1,095 Cr, and management gave no hard quarterly target to test against.
Q2 FY27 consolidated revenue INR 296 Cr (+42%), EBITDA INR 45 Cr (+51%), PAT INR 8 Cr (+144%). Battery Chemicals revenue INR 37 Cr; Organolithium capacity expansion approved.
Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.
Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.
Neogen Chemicals' board approved a capacity addition of 600 MT/PA with a Rs 45.00 Crore investment. Funding will come from internal accruals and debt.
Neogen reports no deviation in QIP fund utilisation for the quarter ended September 30, 2026. This is a periodic utilisation report, not a new transaction.
Neogen Chemicals Ltd reported revenue from operations of ₹296 Cr (+41.8% YoY) and net profit of ₹8.2 Cr (+141.2% YoY) for Q2 FY27.
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
Neogen Chemicals accepted an additional Rs. 152.00 crore insurance claim for Dahej plant fire damage. Total claim receivable stands at Rs. 316.49 crore.
Neogen Chemicals paid monthly interest of ₹1.69 Crore on its ₹200 Cr NCDs (ISIN INE136S07013) on 28 Oct 2026, fulfilling its Reg 57(1) obligation.
Neogen Chemicals Limited intimated a board meeting on 31 October 2026 to approve September 2026 quarter results and other business. The other business is voluntary full redemption of Rs. 200 Crore NCDs.
Neogen Chemicals will meet on 31 October 2026 to consider results and a proposed ₹200 Crore NCD redemption. Both items are proposed only.
Neogen Chemicals Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under Regulation 31(1)(b) of SEBI LODR.
Neogen Chemicals has fixed October 16, 2026, as the record date for the interest payment due on October 31, 2026, for its listed non-convertible debentures.
Neogen Chemicals' subsidiary, Neogen Morita New Materials Limited, approved a preferential issue of 7,20,000 equity shares worth ₹76.80 Crore to Morita Investment Limited.
CRISIL Ratings reaffirmed and revised outlooks for Neogen Chemicals and subsidiary Neogen Ionics' facilities and debt, citing improved financial risk profile and completed QIP funding.
Neogen Chemicals has paid the interest on its listed non-convertible debentures for September 2026, totaling ₹1.63 Crore.
Neogen Chemicals Ltd has submitted its quarterly shareholding pattern disclosure as per SEBI regulations. This routine filing details the current equity distribution among promoters and public shareholders.
Neogen Chemicals Limited allotted equity shares via a Qualified Institutional Placement (QIP). The allotment increases the total paid-up share capital of the company.
Neogen Chemicals is raising funds via a Qualified Institutional Placement of 26.61 lakh equity shares. This issuance is valued at approximately ₹600 Crore.
Neogen Chemicals successfully concluded its QIP, issuing 26,60,753 equity shares at an issue price of ₹2,255 per share, raising funds from qualified institutional buyers.
Neogen Chemicals Limited has opened its Qualified Institutional Placement (QIP) with a floor price of ₹2,189.73 per share, as approved by its Fund-Raising Committee.
Neogen Chemicals received a GST show-cause demand notice for ₹6.97 Crore for FY 2022-23. The company is evaluating the notice and intends to file a response.
Neogen Chemicals Ltd has fixed September 15, 2026, as the record date for the interest payment on its NCDs (ISIN: INE136S07013), payable on September 30, 2026.
Neogen Chemicals approved a Rs. 245 Crore Business Transfer Agreement between its subsidiaries, NIL and NML, to consolidate electrolyte salt manufacturing.
Neogen Chemicals reported a gift transfer of 354 equity shares between two individuals categorized as 'Other'. This off-market transaction involves no monetary consideration.
Mrs. Heena Hitesh Reshamwala (spouse of Mr. Hitesh Reshamwala) gifted 354 equity shares of Neogen Chemicals Ltd to Mr. Viren Reshamwala in an off-market transaction.